Leadership
Management
Ronald J. Zenk
President and CEO
Mr. Zenk is the the President, CEO, member of the Board of Directors and Founder of Humanetics Corporation.
John C. Dykstra
Chief Operating Officer
Mr. Dykstra has served as Chief Operating Officer of Humanetics since 1998 and is a member of the Board of Directors.
Michael D. Kaytor, Ph.D.
Vice President of Research and Development
Dr. Kaytor joined Humanetics in 2012 and serves as the Vice President of Research and Development.
Board of Directors
Admiral Matthew L. Nathan, M.D.
Director
Admiral Nathan has served as a member of the Board since 2020 and as Chairman since 2022.
Medical and Programmatic Advisors
Colin G. Chinn, MD, MHS, FACP
Rear Admiral, U.S. Navy (Ret.)
Dr. Chinn was the 14th Staff Surgeon and senior advisor to the Chairman of the Joint Chiefs.
Zeljko Vujaskovic, MD, Ph.D.
Director of Division of Translational Radiation Sciences, University of Maryland
Dr. Vujaskovic specialized in research and clinical practice in the area of radiation oncology and radiation injury.
Robert C. Miller, MD
Professor of Radiation Oncology, University of Maryland School of Medicine
Dr. Miller is a practicing radiation oncologist within the University of Maryland School of Medicine and is the Medical Director of the Maryland Proton Treatment Center.
Douglas W. Bryce
Advisor - CBRN Medical Countermeasure Contracting.
Mr. Bryce served as the Joint Program Executive Officer, Chemical, Biological, Radiological and Nuclear Defense.
Scientific Advisors
Isabel L. Jackson, Ph.D.
Assistant Professor of Radiation Oncology, University of Maryland
Dr. Jackson's area of expertise is focused on understanding the mechanisms underlying radiation effects in tissue.
Michael R. Landauer, Ph.D.
Scientist Emeritus, Armed Forces Radiobiology Research Institute
Dr. Landauer is a radiation countermeasure consultant.
Ronald G. Manning, Ph.D.
Former Chief, Chemical, Radiological and Nuclear Medical Countermeasures, BARDA
Dr. Manning is a distinguished scientists that has expertise in development of Medical Countermeasures.